{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidxwf762x7iulko3qseeaa5zc2vl3xh6svx5pq6oh2zqcto4uc6fm",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mkcukpgvmnu2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreigj7tio5u6mpkxjlqdwmqwbjokvuyaohnerf2mapvs4bcaky77vse"
    },
    "mimeType": "image/jpeg",
    "size": 54441
  },
  "path": "/2026/04/24/eli-lilly-kelonia-therapeutics-interview/?utm_campaign=rss",
  "publishedAt": "2026-04-24T17:50:39.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "The Readout LOUD",
    "biotech",
    "Eli Lilly",
    "Pharmaceuticals",
    "STAT+",
    "Venture capital"
  ],
  "textContent": "What did Eli Lilly see in a struggling biotech startup that made the pharma giant want to pay billions for it? Bryan Roberts has some answers.",
  "title": "STAT+: A biotech VC on what Eli Lilly saw in a struggling cancer startup for $3.2B",
  "updatedAt": "2026-04-24T19:55:17.000Z"
}